Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Cognitive-behavioral therapy modifies the naturalistic course of social anxiety disorder: findings from an ABA design study in routine clinical practices.

Furukawa TA, Nakano Y, Funayama T, Ogawa S, Ietsugu T, Noda Y, Chen J, Watanabe N, Akechi T.

Psychiatry Clin Neurosci. 2013 Apr;67(3):139-47. doi: 10.1111/pcn.12035.

2.

Attention training toward and away from threat in social phobia: effects on subjective, behavioral, and physiological measures of anxiety.

Heeren A, Reese HE, McNally RJ, Philippot P.

Behav Res Ther. 2012 Jan;50(1):30-9. doi: 10.1016/j.brat.2011.10.005. Epub 2011 Oct 25.

PMID:
22055280
3.

Who Comes, Who Stays, Who Profits? Predicting refusal, dropout, success, and relapse in a short intervention for social phobia.

Marie Lincoln T, Rief W, Hahlweg K, Frank M, Witzleben Iv, Schroeder B, Fiegenbaum W.

Psychother Res. 2005 Jul;15(3):210-25. doi: 10.1080/10503300512331387834. No abstract available.

PMID:
22011151
4.

Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study.

Watanabe N, Furukawa TA, Chen J, Kinoshita Y, Nakano Y, Ogawa S, Funayama T, Ietsugu T, Noda Y.

BMC Psychiatry. 2010 Oct 14;10:81. doi: 10.1186/1471-244X-10-81.

5.

Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review.

Eskildsen A, Hougaard E, Rosenberg NK.

Nord J Psychiatry. 2010 Apr;64(2):94-105. doi: 10.3109/08039480903426929. Review.

PMID:
20055730
6.

Psychological treatment of social anxiety disorder: a meta-analysis.

Acarturk C, Cuijpers P, van Straten A, de Graaf R.

Psychol Med. 2009 Feb;39(2):241-54. doi: 10.1017/S0033291708003590. Epub 2008 May 28.

PMID:
18507874
7.

Group cognitive behavior therapy for Japanese patients with social anxiety disorder: preliminary outcomes and their predictors.

Chen J, Nakano Y, Ietzugu T, Ogawa S, Funayama T, Watanabe N, Noda Y, Furukawa TA.

BMC Psychiatry. 2007 Dec 10;7:69.

8.

Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life.

Beesdo K, Bittner A, Pine DS, Stein MB, Höfler M, Lieb R, Wittchen HU.

Arch Gen Psychiatry. 2007 Aug;64(8):903-12.

PMID:
17679635
9.

Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE.

Arch Gen Psychiatry. 2005 Jun;62(6):593-602. Erratum in: Arch Gen Psychiatry. 2005 Jul;62(7):768. Merikangas, Kathleen R [added].

PMID:
15939837
10.

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM.

Arch Gen Psychiatry. 2004 Oct;61(10):1005-13.

PMID:
15466674
11.

Cognitive mediation of treatment change in social phobia.

Hofmann SG.

J Consult Clin Psychol. 2004 Jun;72(3):393-9.

12.

Considering comorbidity in social phobia.

Chartier MJ, Walker JR, Stein MB.

Soc Psychiatry Psychiatr Epidemiol. 2003 Dec;38(12):728-34.

PMID:
14689178
13.

The lifelong course of social anxiety disorder: a clinical perspective.

Keller MB.

Acta Psychiatr Scand Suppl. 2003;(417):85-94. Review.

PMID:
12950439
14.

The impairments caused by social phobia in the general population: implications for intervention.

Kessler RC.

Acta Psychiatr Scand Suppl. 2003;(417):19-27. Review.

PMID:
12950433
15.

Pharmacological treatment of social anxiety disorder: a meta-analysis.

Blanco C, Schneier FR, Schmidt A, Blanco-Jerez CR, Marshall RD, Sánchez-Lacay A, Liebowitz MR.

Depress Anxiety. 2003;18(1):29-40.

PMID:
12900950
16.

Cognitive-behavioral therapy for social anxiety disorder: current status and future directions.

Heimberg RG.

Biol Psychiatry. 2002 Jan 1;51(1):101-8. Review.

PMID:
11801235
17.

The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats.

Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, Goetz D.

Psychol Med. 2001 Aug;31(6):1025-35.

PMID:
11513370
18.

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia.

Blomhoff S, Haug TT, Hellström K, Holme I, Humble M, Madsbu HP, Wold JE.

Br J Psychiatry. 2001 Jul;179:23-30.

19.

Social phobia or social anxiety disorder: what's in a name?

Liebowitz MR, Heimberg RG, Fresco DM, Travers J, Stein MB.

Arch Gen Psychiatry. 2000 Feb;57(2):191-2. No abstract available.

PMID:
10665624
20.

Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.

Liebowitz MR, Heimberg RG, Schneier FR, Hope DA, Davies S, Holt CS, Goetz D, Juster HR, Lin SH, Bruch MA, Marshall RD, Klein DF.

Depress Anxiety. 1999;10(3):89-98.

PMID:
10604081

Supplemental Content

Support Center